ArticlePloS one2020

Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.

Kathiaja Miranda Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.